Newsletter Issue 01/2019

Instruction no. 25, dated 17.1.2019 "On approval of the Regulation on Pharmaceutical Advertising"

On 17.1.2019 the Minister of Health and Social Protection based on Law no. 105, dated 31.7.2014 "On Medicinal Products and Pharmaceutical Service" approved Instruction no. 25, dated 17.1.2019 "On approval of the Regulation on Pharmaceutical Advertising", (the "Regulation"), which was published in the Official Journal on 12.2.2019.

The Regulation aims to define rules for the advertising of medicinal products addressed to the general public and provides that the Authority responsible for implementing the Regulation is the National Agency for Medicinal Products and Medicinal Devices.

One of the main principles of advertising of the medicinal products, consists in providing true information, which is scientifically proven and complies with ethical criteria to ensure an adequate and rational treatment of the patient.

Advertising to General Public

Advertising to general public is only allowed for medicinal products that are part of the list of OTC medicines. Advertising to the general public of medicinal products which are only available on medical prescription is normally, prohibited except for awareness raising campaigns or activities of public health institutions which are conducted in line with the programs adopted...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT